Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Erytech Pharma ADR (ERYP)

Erytech Pharma ADR (ERYP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Erytech Pharma ADR 60 Avenue Rockefeller Lyon I0 69008 FRA

www.erytech.com P: 33-4-78-74-44-38

Description:

Erytech Pharma S.A. operates as a biopharmaceutical company. It discovers and developes therapies for rare forms of cancer and orphan diseases. The company's product pipeline consists of eryaspase, erymethionase, eryminase, ERYZYME and ERYMMUNE which are in clinical stages. It operates primarily in France and the United States. Erytech Pharma S.A. is based in France.

Key Statistics

Overview:

Market Capitalization, $K 26,614
Enterprise Value, $K -3,606
Shares Outstanding, K 34,120
Annual Sales, $ 32,660 K
Annual Net Income, $ -240 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ 5,935 K
60-Month Beta 2.69
% of Insider Shareholders 1.94%
% of Institutional Shareholders 1.09%
Float, K 33,458
% Float 98.06%
Short Volume Ratio 0.27

Growth:

1-Year Return -31.58%
3-Year Return -90.25%
5-Year Return -95.65%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -26.13%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 04/26/23
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ERYP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -0.73%
Debt/Equity 0.32
Price/Sales 0.81
Price/Cash Flow N/A
Price/Book 0.98
Book Value/Share 0.80
Interest Coverage -1.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar